The importance of including the C-terminal domain of PTP1B_1-400 to identify potential antidiabetic inhibitors

References

• Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement_1):S15–S33.
   PubMedGoogle Scholar
• Kerru N, Singh-Pillay A, Awolade P, Singh P. Current anti-diabetic agents and their molecular targets: a review. Eur J Med Chem. 2018;152:436–488.
   PubMed Web of Science ®Google Scholar
• Martin JL, Baxter RC. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors. 2011;29(6):235–244.
   PubMed Web of Science ®Google Scholar
• Møller NP, Iversen LF, Andersen HS, McCormack JG. Protein tyrosine phosphatases (PTPs) as drug targets: inhibitors of PTP-1B for the treatment of diabetes. Curr Opin Drug Discov Devel. 2000;3(5):527–540.
   PubMedGoogle Scholar
• Koren S, Fantus IG. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab. 2007;21(4):621–640.
   PubMed Web of Science ®Google Scholar
• Bakke J, Haj FG. Protein-tyrosine phosphatase 1B substrates and metabolic regulation. Semin Cell Dev Biol. 2015;37:58–65.
   PubMed Web of Science ®Google Scholar
• Krishnan N, Koveal D, Miller DH, Xue B, Akshinthala SD, Kragelj J, Jensen MR, Gauss CM, Page R, Blackledge M, et al. Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol. 2014;10(7):558–566.
   PubMed Web of Science ®Google Scholar
• Tan XF, Uddin Z, Park C, Song YH, Son M, Lee KW, Park KH. Competitive protein tyrosine phosphatase 1B (PTP1B) inhibitors, prenylated caged xanthones from Garcinia hanburyi and their inhibitory mechanism. Bioorg Med Chem. 2017;25(8):2498–2506.
   PubMed Web of Science ®Google Scholar
• Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem. 2000; 275(6):4283–4289.
   PubMed Web of Science ®Google Scholar
• González-Rodríguez Á, Más-Gutierrez JA, Mirasierra M, Fernandez-Pérez A, Lee YJ, Ko HJ, Kim JK, Romanos E, Carrascosa JM, Ros M, et al. Essential role of protein tyrosine phosphatase 1B in obesity-induced inflammation and peripheral insulin resistance during aging. Aging Cell. 2012; 11(2):284–296.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Bettaieb A, Nagata N, Matsuo I, Keilhack H, Haj FG. Regulation of brown fat adipogenesis by protein tyrosine phosphatase 1B. PLOS One. 2011;6(1):e16446.
   PubMed Web of Science ®Google Scholar
• Nandi S, Saxena M. Potential inhibitors of protein tyrosine phosphatase (PTP1B) enzyme: promising target for type-II diabetes mellitus. Curr Top Med Chem. 2020;20(29):2692–2707.
   PubMed Web of Science ®Google Scholar
• Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest. 1997;100(2):449–458.
   PubMed Web of Science ®Google Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283(5407):1544–1548.
   PubMed Web of Science ®Google Scholar
• Xue B, Kim YB, Lee A, Toschi E, Bonner-Weir S, Ronald Kahn C, Neel BG, Kahn BB. Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem. 2007;282(33):23829–23840.
   PubMed Web of Science ®Google Scholar
• Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Joharapurkar A, Dhanesha N, Shaikh M, Sairam KVVM, Kapadnis P. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors. Bioorg Med Chem Lett. 2012;22(2):1111–1117.
   PubMed Web of Science ®Google Scholar
• Sarabia-Sánchez MJ, Trejo-Soto PJ, Velázquez-López JM, Carvente-García C, Castillo R, Hernández-Campos A, Avitia-Domínguez C, Enríquez-Mendiola D, Sierra-Campos E, Valdez-Solana M, et al. Novel mixed-type inhibitors of protein tyrosine phosphatase 1B. Kinetic and computational studies. Molecules. 2017;22(12):2262.
   PubMed Web of Science ®Google Scholar
• Kumar GS, Page R, Petiid W. The mode of action of the Protein tyrosine phosphatase 1B inhibitor ertiprotafib; 2020. Available from:
   Google Scholar
• An JP, Ha TKQ, Kim J, Cho TO, Oh WK. Protein tyrosine phosphatase 1B inhibitors from the stems of Akebia quinata. Molecules. 2016;21(8):1091.
   PubMed Web of Science ®Google Scholar
• Erbe DV, Wang S, Zhang YL, Harding K, Kung L, Tam M, Stolz L, Xing Y, Furey S, Qadri A, et al. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Mol Pharmacol. 2005;67(1):69–77.
   PubMed Web of Science ®Google Scholar
• Luo J, Zheng M, Jiang B, Li C, Guo S, Wang L, Li X, Yu R, Shi D. Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides. Br J Pharmacol. 2020;177(19):4464–4480.
   PubMed Web of Science ®Google Scholar
• Hussain H, Green IR, Abbas G, Adekenov SM, Hussain W, Ali I. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015–2018). Expert Opin Ther Pat. 2019; 29(9):689–702.
   PubMed Web of Science ®Google Scholar
• Balaramnavar VM, Srivastava R, Varshney S, Kumar S, Rawat AK, Chandasana H, Chhonker YS, Bhatta RS, Srivastava AK, Gaikwad AN, et al. Synthesis, biological evaluation, and molecular docking study of some new rohitukine analogs as protein tyrosine phosphatase 1B inhibitors. Bioorg Chem. 2021;110:104829.
   PubMed Web of Science ®Google Scholar
• García-Marín J, Griera M, Alajarín R, Rodríguez-Puyol M, Rodríguez-Puyol D, Vaquero JJ. A Computer-driven scaffold-hopping approach generating new PTP1B inhibitors from the pyrrolo[1,2-a]quinoxaline core. ChemMedChem. 2021;16(18):2895–2906.
   PubMed Web of Science ®Google Scholar
• Sánchez-Alonso P, Griera M, García-Marín J, Rodríguez-Puyol M, Alajarín R, Vaquero JJ, Rodríguez-Puyol D. Pyrrolo[1,2-a]quinoxal-5-inium salts and 4,5-dihydropyrrolo[1,2-a]quinoxalines: synthesis, activity and computational docking for protein tyrosine phosphatase 1B. Bioorg Med Chem. 2021;44:116295.
   PubMed Web of Science ®Google Scholar
• Campos-Almazán MI, Hernández-Campos A, Castillo R, Sierra-Campos E, Valdez-Solana M, Avitia-Domínguez C. Téllez-Valencia A. Computational methods in cooperation with experimental approaches to design protein tyrosine phosphatase 1B inhibitors in type 2 diabetes drug design: a review of the achievements of this century. Pharmaceuticals. 2022;15(7):866.
   Web of Science ®Google Scholar
• Xu L, Mu X, Liu M, Wang Z, Shen C, Mu Q, Feng B, Xu Y, Hou T, Gao L, et al. Novel thieno[2,3-b]quinoline-procaine hybrid molecules: a new class of allosteric SHP-1 activators evolved from PTP1B inhibitors. Chin Chem Lett. 2022:108063.
   Web of Science ®Google Scholar
• De-La-Cruz-Martínez L, Duran-Becerra C, González-Andrade M, Páez-Franco JC, Germán-Acacio JM, Espinosa-Chávez J, Torres-Valencia JM, Pérez-Villanueva J, Palacios-Espinosa JF, Soria-Arteche O, et al. Indole- and pyrazole-glycyrrhetinic acid derivatives as PTP1B inhibitors: synthesis, in vitro and in silico studies. Molecules. 2021;26(14):4375.
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Clemens JC, Schubert HL, Stuckey JA, Fischer MWF, Hume DM, Saper MA, Dixon JE. Expression, purification, and physicochemical characterization of a recombinant Yersinia protein tyrosine phosphatase. J Biol Chem. 1992;267(33):23759–23766.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al. Highly accurate protein structure prediction with alpha fold. Nature. 2021;596(7873):583–589.
   PubMed Web of Science ®Google Scholar
• Pérez-Vásquez A, Díaz-Rojas M, Castillejos-Ramírez EV, Pérez-Esquivel A, Montaño-Cruz Y, Rivero-Cruz I, Torres-Colín R, González-Andrade M, Rodríguez-Sotres R, Gutiérrez-González JA, et al. Protein tyrosine phosphatase 1B inhibitory activity of compounds from Justicia spicigera (Acanthaceae). Phytochemistry. 2022;203:113410.
   PubMed Web of Science ®Google Scholar
• Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012;4(1):17–17.
   PubMed Web of Science ®Google Scholar
• Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11(5):905–919.
   PubMed Web of Science ®Google Scholar
• DeLano W. Use of PYMOL as a communications tool for molecular science – ScienceOpen. Abst Paper Am Chem Soc. 2004;228:U313–U314.
   Web of Science ®Google Scholar
• Liu G, Xin Z, Liang H, Abad-Zapatero C, Hajduk PJ, Janowick DA, Szczepankiewicz BG, Pei Z, Hutchins CW, Ballaron SJ, et al. Selective protein tyrosine phosphatase 1B inhibitors: Targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands. J Med Chem. 2003;46(16):3437–3440.
   PubMed Web of Science ®Google Scholar
• Kyriakou E, Schmidt S, Dodd GT, Pfuhlmann K, Simonds SE, Lenhart D, Geerlof A, Schriever SC, De Angelis M, Schramm KW, et al. Celastrol promotes weight loss in diet-induced obesity by inhibiting the protein tyrosine phosphatases PTP1B and TCPTP in the hypothalamus. J Med Chem. 2018;61(24):11144–11157.
   PubMed Web of Science ®Google Scholar
• Andersen HS, Iversen LF, Jeppesen CB, Branner S, Norris K, Rasmussen HB, Moller KB, Møller NPH. 2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases. J Biol Chem. 2000;275(10):7101–7108.
   PubMed Web of Science ®Google Scholar
• Xin Z, Liu G, Abad-Zapatero C, Pei Z, Szczepankiewicz BG, Li X, Zhang T, Hutchins CW, Hajduk PJ, Ballaron SJ, et al. Identification of a monoacid-based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett. 2003;13(22):3947–3950.
   PubMed Web of Science ®Google Scholar
• Baskaran SK, Goswami N, Selvaraj S, Muthusamy VS, Lakshmi BS. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid. J Chem Inf Model. 2012;52(8):2004–2012.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Keng YF, Zhao Y, Wu L, Zhang ZY. Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases. J Biol Chem. 1998;273(20):12281–12287.
   PubMed Web of Science ®Google Scholar
• Denu JM, Lohse DL, Vijayalakshmi J, Saper MA, Dixon JE. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc Natl Acad Sci USA. 1996;93(6):2493–2498.
   PubMed Web of Science ®Google Scholar
• Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem. 1997;272(2):843–851.
   PubMed Web of Science ®Google Scholar
• Lantz KA, Hart SGE, Planey SL, Roitman MF, Ruiz-White IA, Wolfe HR, McLane MP. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obesity. 2010;18(8):1516–1523.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Li W, Wang J, Li N, Cheng MS, Koike K. Protein tyrosine phosphatase 1B inhibitory activities of ursane-type triterpenes from Chinese raspberry, fruits of Rubus chingii. Chin J Nat Med. 2019;17(1):15–21.
   PubMed Web of Science ®Google Scholar
• Zhao BT, Nguyen DH, Le DD, Choi JS, Min BS, Woo MH. Protein tyrosine phosphatase 1B inhibitors from natural sources. Arch Pharm Res. 2018;41(2):130–161.
   PubMed Web of Science ®Google Scholar
• Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li J. y, Hu L. h, Li J. Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta. 2006;1760(10):1505–1512.
   PubMed Web of Science ®Google Scholar
• Lipchock JM, Hendrickson HP, Douglas BB, Bird KE, Ginther PS, Rivalta I, Ten NS, Batista VS, Loria JP. Characterization of protein tyrosine phosphatase 1B inhibition by chlorogenic acid and cichoric acid. Biochemistry. 2017;56(1):96–106.
   PubMed Web of Science ®Google Scholar
• Krishnan N, Konidaris KF, Gasser G, Tonks NK. A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models. J Biol Chem. 2018;293(5):1517–1525.
   PubMed Web of Science ®Google Scholar
• Tian Zhao B, Hung Nguyen D, Mi Lee B, Hui Seong S, Sue Choi J, Sun Min B, Hee Woo M. PTP1B inhibitory and cytotoxic activities of triterpenoids from the aerial parts of Agrimonia pilosa. Med Chem Res. 2017;26(11):2870–2878.
   Web of Science ®Google Scholar
• McCain DF, Wu L, Nickel P, Kassack MU, Kreimeyer A, Gagliardi A, Collins DC, Zhang ZY. Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases. J Biol Chem. 2004;279(15):14713–14725.
   PubMed Web of Science ®Google Scholar
• Villamar-Cruz O, Loza-Mejia MA, Arias-Romero LE, Camacho-Arroyo I. Recent advances in PTP1B signaling in metabolism and cancer. Biosci Rep. 2021;41(11):BSR20211994.
   PubMed Web of Science ®Google Scholar